Back to Search
Start Over
Nicolau syndrome following subcutaneous glatiramer acetate injection: A case report and review of the literature.
- Source :
-
Indian journal of pharmacology [Indian J Pharmacol] 2021 Nov-Dec; Vol. 53 (6), pp. 489-492. - Publication Year :
- 2021
-
Abstract
- Nicolau syndrome is a rare serious drug reaction associated with the administering various injectable medications. It is often characterized by an acute and severe pain accompanying erythema that tends to rapidly evolve into the livedoid reticular or hemorrhagic patches and less commonly to ulcers and skin necrosis. Herein, we report a 34-year-old woman who presented with painful, tender discoloration over her abdominal skin following subcutaneous glatiramer acetate injection. Since the patient was diagnosed with multiple sclerosis 18 months ago, she had been on treatment with subcutaneous glatiramer acetate injections thrice weekly. The patient was diagnosed with Nicolau syndrome clinically and histopathologically. After 15-day treatment with topical betamethasone valerate and mucopolysaccharide polysulfate cream twice daily, the lesion completely regressed with only minimal hypopigmented irregular scarring. Nicolau syndrome should be considered in patients with severe pain, tenderness, and redness localized at the injection site following glatiramer subacetate.<br />Competing Interests: None
- Subjects :
- Adult
Antirheumatic Agents administration & dosage
Diagnosis, Differential
Female
Glatiramer Acetate administration & dosage
Humans
Injections, Subcutaneous
Multiple Sclerosis drug therapy
Nicolau Syndrome etiology
Nicolau Syndrome pathology
Antirheumatic Agents adverse effects
Glatiramer Acetate adverse effects
Nicolau Syndrome diagnosis
Subjects
Details
- Language :
- English
- ISSN :
- 1998-3751
- Volume :
- 53
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Indian journal of pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 34975138
- Full Text :
- https://doi.org/10.4103/ijp.ijp_166_21